High-dialysate-glucose-induced oxidative stress and mitochondrial-mediated apoptosis in human peritoneal mesothelial cells

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Hung, Kuan Yu ^a   Liu, Shin Yun ^a,b   Yang, Te Cheng ^c   Liao, Tien Ling ^b,d   Kao, Shu Huei ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; DIALYSIS; DIALYSIS MEMBRANES; MITOCHONDRIA;

FUNCTIONAL CHANGES; GLUCOSE CONCENTRATION; LIPID PEROXIDATION; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL FRAGMENTATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PERITONEAL DIALYSIS; REACTIVE OXYGEN SPECIES;

GLUCOSE;

ACETYLCYSTEINE; CASPASE; CYTOCHROME C; GLUCOSE; LIPID; MITOCHONDRIAL DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; DIALYSIS FLUID;

APOPTOSIS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIALYSATE LEVEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA FRAGMENTATION; ENZYME ACTIVATION; HIGH DIALYSATE GLUCOSE INDUCED APOPTOSIS; HUMAN; HUMAN CELL; HUMAN PERITONEAL MESOTHELIAL CELL; INCUBATION TIME; LIPID PEROXIDATION; MESOTHELIUM CELL; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; OXIDATIVE STRESS; PERITONEUM CELL; PROTEIN SECRETION; CELL CULTURE; CYTOLOGY; DNA DAMAGE; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; MITOCHONDRION; PERITONEUM;

ACETYLCYSTEINE; APOPTOSIS; CASPASES; CELLS, CULTURED; CYTOCHROMES C; DIALYSIS SOLUTIONS; DNA DAMAGE; EPITHELIAL CELLS; GLUCOSE; HUMANS; LIPID PEROXIDATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OXIDATIVE STRESS; PERITONEUM; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE OXYGEN SPECIES;

EID: 84901937976     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/642793     Document Type: Article

References (31)

1. García-López E., Lindholm B., Davies S., An update on peritoneal dialysis solutions. Nature Reviews Nephrology 2012 8 4 224 233 2-s2.0-84859002297 10.1038/nrneph.2012.13
2. Fenton S. S. A., Schaubel D. E., Desmeules M., Morrison H. I., Mao Y., Copleston P., Jeffery J. R., Kjellstrand C. M., Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. American Journal of Kidney Diseases 1997 30 3 334 342 2-s2.0-0030805988 (Pubitemid 27391500)
3. Williams J. D., Craig K. J., von Ruhland C., Topley N., Williams G. T., The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney International 2003 64 88 S43 S49 2-s2.0-0344874202 (Pubitemid 37452813)
4. Higuchi C., Nishimura H., Sanaka T., Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis. Therapeutic Apheresis and Dialysis 2006 10 4 372 379 2-s2.0-33746660666 10.1111/j.1744-9987.2006.00391.x (Pubitemid 44154768)
5. Williams J. D., Craig K. J., Topley N., Von Ruhland C., Fallon M., Newman G. R., Mackenzie R. K., Williams G. T., Morphologic changes in the peritoneal membrane of patients with renal disease. Journal of the American Society of Nephrology 2002 13 2 470 479 2-s2.0-0036158071 (Pubitemid 34106290)
6. Ksizek K., Korybalska K., Jörres A., Witowski J., Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF- β 1. Laboratory Investigation 2007 87 4 345 356 2-s2.0-33947529233 10.1038/labinvest.3700519 (Pubitemid 46474562)
7. Boulanger E., Wautier M.-P., Gane P., Mariette C., Devuyst O., Wautier J.-L., The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Nephrology Dialysis Transplantation 2004 19 9 2208 2216 2-s2.0-4544300340 10.1093/ndt/gfh277 (Pubitemid 39214112)
8. Mishra R., Emancipator S. N., Kern T., Simonson M. S., High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney International 2005 67 1 82 93 2-s2.0-10944263493 10.1111/j.1523-1755.2005.00058. x (Pubitemid 40019229)
9. Hung K.-Y., Huang J.-W., Chiang C.-K., Tsai T.-J., Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies. Nephrology Dialysis Transplantation 2008 23 12 3831 3840 2-s2.0-56749132083 10.1093/ndt/gfn369
10. Wang X., The expanding role of mitochondria in apoptosis. Genes and Development 2001 15 22 2922 2933 2-s2.0-0035890085 (Pubitemid 33078942)
11. Parsons M. J., Green D. R., Mitochondria in cell death. Essays in Biochemistry 2010 47 99 114 2-s2.0-78549279860
12. Raha S., Robinson B. H., Mitochondria, oxygen free radicals, and apoptosis. American Journal of Medical Genetics 2001 106 1 62 70 2-s2.0-0034951169 10.1002/ajmg.1398 (Pubitemid 32601619)
13. Green K., Brand M. D., Murphy M. P., Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 2004 53 1 S110 S118 2-s2.0-0842328003 (Pubitemid 38168702)
14. Kang B. P. S., Frencher S., Reddy V., Kessler A., Malhorta A., Meggs L. G., High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. American Journal of Physiology. Renal Physiology 2003 284 3 F455 F466 2-s2.0-0037369416 (Pubitemid 36227906)
15. D'Amours D., Sallmann F. R., Dixit V. M., Poirier G. G., Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. Journal of Cell Science 2001 114 20 3771 3778 2-s2.0-0034760530 (Pubitemid 33041059)
16. Al-Kafaji G., Golbahar J., High glucose-induced oxidative stress increases the copy number of mitochondrial DNA in human mesangial cells. BioMed Research International 2013 2013 8 10.1155/2013/754946 754946
17. Zhu X., Ling G., Xiao L., Liu Y., Duan S., Peng Y., Kanwar Y. S., Sun L., Liu F., Role of mitochondrial respiratory chain complex III in high glucose peritoneal dialysate-induced hyperpermeability of HPMCs. Renal Failure 2010 32 9 1103 1108 2-s2.0-77957283908 10.3109/0886022X.2010.504912
18. Galloway C. A., Yoon Y., Perspectives on: SGP symposium on mitochondrial physiology and medicine: what comes first, misshape or dysfunction? The view from metabolic excess. The Journal of General Physiology 2012 139 6 455 463
19. Nakabeppu Y., Sakumi K., Sakamoto K., Tsuchimoto D., Tsuzuki T., Nakatsu Y., Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids. Biological Chemistry 2006 387 4 373 379 2-s2.0-33745485302 10.1515/BC.2006.050
20. Suzuki S., Hinokio Y., Komatu K., Ohtomo M., Onoda M., Hirai S., Hirai M., Hirai A., Chiba M., Kasuga S., Akai H., Toyota T., Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Research and Clinical Practice 1999 45 2-3 161 168 2-s2.0-0032882037 10.1016/S0168-8227(99)00046-7 (Pubitemid 29457764)
21. Al-Shabrawey M., Smith S., Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers. EPMA Journal 2010 1 1 56 72 2-s2.0-79953039898 10.1007/s13167-010-0002-9
22. Chen H., Detmer S. A., Ewald A. J., Griffin E. E., Fraser S. E., Chan D. C., Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. Journal of Cell Biology 2003 160 2 189 200 2-s2.0-0037455575 10.1083/jcb.200211046 (Pubitemid 36254953)
23. Spinazzi M., Cazzola S., Bortolozzi M., Baracca A., Loro E., Casarin A., Solaini G., Sgarbi G., Casalena G., Cenacchi G., Malena A., Frezza C., Carrara F., Angelini C., Scorrano L., Salviati L., Vergani L., A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. Human Molecular Genetics 2008 17 21 3291 3302 2-s2.0-54449084658 10.1093/hmg/ddn225
24. Widlansky M. E., Wang J., Shenouda S. M., Hagen T. M., Smith A. R., Kizhakekuttu T. J., Kluge M. A., Weihrauch D., Gutterman D. D., Vita J. A., Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes. Translational Research 2010 156 1 15 25 2-s2.0-77953583649 10.1016/j.trsl.2010.04.001
25. Youle R. J., Karbowski M., Mitochondrial fission in apoptosis. Nature Reviews Molecular Cell Biology 2005 6 8 657 663 2-s2.0-23144451432 10.1038/nrm1697 (Pubitemid 41081269)
26. Zhu M., Li W. W., Lu C. Z., Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+. CNS Neuroscience & Therapeutics 20 4 308 316
27. Coombes J. S., Fassett R. G., Antioxidant therapy in hemodialysis patients: a systematic review. Kidney International 2012 81 3 233 246 2-s2.0-84856723098 10.1038/ki.2011.341
28. Himmelfarb J., Ikizler T. A., Ellis C., Wu P., Shintani A., Dalal M S., Kaplan M., Chonchol, Hakim R. M., Provision of Antioxidant Therapy in Hemodialysis (PATH): a randomized clinical trial. Journal of the American Society of Nephrology 2014 25 3 623 633
29. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M. S., Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. The Lancet 2000 356 9237 1213 1218 2-s2.0-0034619027
30. Tepel M., van der Giet M., Statz M., Jankowski J., Zidek W., The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 2003 107 7 992 995 2-s2.0-0037465546 10.1161/01.CIR.0000050628.11305.30 (Pubitemid 36258722)
31. Boudouris G., Verginadis I. I., Simos Y. V., Zouridakis A., Ragos V., Karkabounas S. Ch., Evangelou A. M., Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation. International Urology and Nephrology 2013 45 1137 1144